Chemed Price to Book Ratio 2010-2024 | CHE

Historical price to book ratio values for Chemed (CHE) over the last 10 years. The current price to book ratio for Chemed as of November 22, 2024 is 6.95.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Chemed Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2024-11-21 563.28 6.80
2024-09-30 600.43 $82.78 7.25
2024-06-30 541.62 $80.51 6.73
2024-03-31 640.79 $78.46 8.17
2023-12-31 583.32 $73.69 7.92
2023-09-30 518.08 $67.91 7.63
2023-06-30 539.56 $63.42 8.51
2023-03-31 535.28 $58.84 9.10
2022-12-31 507.72 $53.70 9.46
2022-09-30 433.91 $48.73 8.90
2022-06-30 466.18 $46.16 10.10
2022-03-31 502.72 $44.74 11.24
2021-12-31 524.65 $41.79 12.55
2021-09-30 460.93 $50.87 9.06
2021-06-30 469.86 $55.59 8.45
2020-12-31 526.63 $56.65 9.30
2020-09-30 474.63 $50.48 9.40
2020-06-30 445.40 $47.39 9.40
2020-03-31 427.46 $43.28 9.88
2019-12-31 433.11 $45.58 9.50
2021-03-31 455.01 $58.51 7.78
2019-09-30 411.40 $42.21 9.75
2019-06-30 355.25 $39.05 9.10
2019-03-31 314.82 $37.08 8.49
2018-12-31 278.38 $37.25 7.47
2018-09-30 313.76 $35.67 8.80
2018-06-30 315.65 $34.76 9.08
2018-03-31 267.41 $31.98 8.36
2017-12-31 237.91 $33.69 7.06
2017-09-30 197.56 $30.08 6.57
2017-06-30 199.70 $28.48 7.01
2017-03-31 178.14 $31.30 5.69
2016-12-31 156.19 $32.38 4.82
2016-09-30 137.10 $30.22 4.54
2016-06-30 132.23 $28.69 4.61
2016-03-31 131.16 $29.46 4.45
2015-12-31 144.79 $30.55 4.74
2015-09-30 128.80 $29.12 4.42
2015-06-30 126.30 $28.41 4.45
2015-03-31 114.83 $28.07 4.09
2014-12-31 101.43 $26.72 3.80
2014-09-30 98.57 $25.57 3.86
2014-06-30 89.58 $25.86 3.46
2013-12-31 72.90 $25.53 2.86
2013-09-30 67.85 $24.34 2.79
2013-06-30 68.54 $25.93 2.64
2013-03-31 75.49 $25.73 2.93
2012-12-31 64.59 $24.46 2.64
2014-03-31 85.31 $25.57 3.34
2012-09-30 65.06 $24.73 2.63
2012-06-30 56.59 $23.55 2.40
2012-03-31 58.52 $22.71 2.58
2011-12-31 47.69 $21.71 2.20
2011-09-30 51.04 $21.55 2.37
2011-06-30 60.67 $22.97 2.64
2011-03-31 61.55 $21.91 2.81
2010-12-31 58.56 $21.71 2.70
2010-09-30 52.41 $23.51 2.23
2010-06-30 50.13 $22.61 2.22
2010-03-31 49.79 $21.91 2.27
2009-12-31 43.82 $21.10 2.08
2009-09-30 39.99 $20.26 1.97
2009-06-30 35.87 $19.42 1.85
2009-03-31 35.29 $18.56 1.90
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $8.593B $2.264B
Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.458B 11.77
Quest Diagnostics (DGX) United States $18.259B 18.51
DaVita (DVA) United States $13.572B 17.55
Encompass Health (EHC) United States $10.188B 24.02
Elanco Animal Health (ELAN) United States $6.605B 15.72
RadNet (RDNT) United States $6.073B 134.49
Option Care Health (OPCH) United States $3.936B 18.65
Amedisys (AMED) United States $2.969B 21.13
LifeStance Health (LFST) United States $2.832B 0.00
Astrana Health (ASTH) United States $2.369B 32.39
Addus HomeCare (ADUS) United States $2.254B 26.45
U.S Physical Therapy (USPH) United States $1.477B 38.82
Aveanna Healthcare Holdings (AVAH) United States $1.128B 0.00
Pennant (PNTG) United States $1.070B 43.25
Atai Life Sciences (ATAI) Germany $0.270B 0.00
Daxor (DXR) United States $0.045B 0.00
Psychemedics (PMD) United States $0.014B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.008B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00